Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment
Clinical trial NCT05443230 · UNKNOWN
Trial details
- NCT number
- NCT05443230
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.